en

Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds Barros, Andrea Barbieri; Rodrigues, Alex Miranda; Batista, Mariane Pereira; Junior, Sidney Munhoz; Hueb, Marcia & Fontes, Cor Jesus Abstract Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported. Keywords leishmaniasis; herpes zoster; antimony therapy

© Copyright 2014 - Memórias do Instituto Oswaldo Cruz
Alternative site location: http://memorias.ioc.fiocruz.br